Abstract

KIF3A, a component of the kinesin-2 motor, is necessary for the progression of diverse tumor types. This is partly due to its role in regulating ciliogenesis and cell responsiveness to sonic hedgehog (SHH). Notably, primary cilia have been detected in human glioblastoma multiforme (GBM) tumor biopsies and derived cell lines. Here, we asked whether disrupting KIF3A in GBM cells affected ciliogenesis, in vitro growth and responsiveness to SHH, or tumorigenic behavior in vivo. We used a lentiviral vector to create three patient-derived GBM cell lines expressing a dominant negative, motorless form of Kif3a (dnKif3a). In all unmodified lines, we found that most GBM cells were capable of producing ciliated progeny and that dnKif3a expression in these cells ablated ciliogenesis. Interestingly, unmodified and dnKif3a-expressing cell lines displayed differential sensitivities and pathway activation to SHH and variable tumor-associated survival following mouse xenografts. In one cell line, SHH-induced cell proliferation was prevented in vitro by either expressing dnKif3a or inhibiting SMO signaling using cyclopamine, and the survival times of mice implanted with dnKif3a-expressing cells were increased. In a second line, expression of dnKif3a increased the cells' baseline proliferation while, surprisingly, sensitizing them to SHH-induced cell death. The survival times of mice implanted with these dnKif3a-expressing cells were decreased. Finally, expression of dnKif3a in a third cell line had no effect on cell proliferation, SHH sensitivity, or mouse survival times. These findings indicate that KIF3A is essential for GBM cell ciliogenesis, but its role in modulating GBM cell behavior is highly variable.

Highlights

  • Less than 5% of patients diagnosed with glioblastoma multiforme (GBM) survive over five years following diagnosis, despite resection, chemotherapy, and radiation treatment [1]

  • Since we had found that KIF3A was critical for GBM cilia formation, and other studies had shown that KIF3A was essential for cilia-mediated sonic hedgehog (SHH) signaling in some tumors and SHH pathways are active in GBM, we examined whether loss of cilia in dnKif3a-expressing cells would change these cells’ responsiveness to SHH

  • Our results show that targeting KIF3A by lentiviral delivery of dnKif3a in GBM cells is a potent method for disrupting ciliogenesis

Read more

Summary

Introduction

Less than 5% of patients diagnosed with GBM survive over five years following diagnosis, despite resection, chemotherapy, and radiation treatment [1]. Extending this survival period is dependent on improving our understanding of the cellular and molecular pathways that enable GBM cells to survive and thrive within the tumor environment [2, 3]. One of the first reports that studied the function of Kif3a in mouse medulloblastoma showed that constitutively active SMO-driven tumor formation is inhibited by loss of KIF3a [13]. Despite its observed roles in the previous tumor types, little is known about the roles of KIF3A in GBM

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call